J.P. Marvel Investment Advisors, LLC Eli Lilly & CO Transaction History

J.P. Marvel Investment Advisors, LLC

$607 Million
Q2 2024

A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 55,868 shares of LLY stock, worth $49.6 Million. This represents 8.33% of its overall portfolio holdings.

Number of Shares

55,868

Previous 55,938 0.13%

Holding current value

$49.6 Million

Previous $43.5 Million 16.23%

% of portfolio

8.33%

Previous 7.54%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $50,740 - $63,632	-70 Reduced 0.13%	55,868 $50.6 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $78,762 - $105,373	-133 Reduced 0.24%	55,938 $43.5 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $149,153 - $175,832	-284 Reduced 0.5%	56,071 $32.7 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $10,867 - $14,982	-25 Reduced 0.04%	56,355 $30.3 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $21,044 - $28,138	-60 Reduced 0.11%	56,380 $26.4 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $227,691 - $267,413	-733 Reduced 1.28%	56,440 $19.4 Million
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $10,289 - $11,989	-32 Reduced 0.06%	57,173 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $81,532 - $92,914	-275 Reduced 0.48%	57,205 $18.5 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $9,755 - $11,454	-35 Reduced 0.06%	57,480 $18.6 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $14,081 - $17,499	-60 Reduced 0.1%	57,515 $16.5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $41,597 - $51,622	185 Added 0.32%	57,575 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $46,979 - $57,814	212 Added 0.37%	57,390 $13.3 Million
Q2 2021 Sep 09, 2021	SELL	$180.55 - $233.54 $9,027 - $11,677	-50 Reduced 0.09%	57,178 $13.1 Million
Q1 2021 Sep 09, 2021	SELL	$164.32 - $212.72 $2,464 - $3,190	-15 Reduced 0.03%	57,228 $10.7 Million
Q2 2020 Sep 09, 2021	SELL	$136.42 - $164.18 $23,327 - $28,074	-171 Reduced 0.3%	57,243 $9.4 Million
Q1 2020 Sep 09, 2021	BUY	$119.05 - $147.35 $30,953 - $38,311	260 Added 0.45%	57,414 $7.96 Million
Q3 2019 Nov 20, 2019	SELL	$106.79 - $116.16 $33,532 - $36,474	-314 Reduced 0.55%	57,154 $6.39 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $1,059 - $1,186	-10 Reduced 0.02%	57,468 $6.65 Million
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $5,299 - $6,081	-70 Reduced 0.12%	57,478 $4.91 Million
Q1 2018 May 16, 2018	SELL	$74.21 - $87.6 $55,880 - $65,962	-753 Reduced 1.29%	57,548 $4.45 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $29,006 - $31,113	-354 Reduced 0.6%	58,301 $4.92 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $134,487 - $149,267	1,745 Added 3.07%	58,655 $5.02 Million
Q2 2017 Aug 24, 2017	BUY	N/A	56,910	56,910 $4.68 Million

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.

Account

J.P. Marvel Investment Advisors, LLC Eli Lilly & CO Transaction History